Abstract
Attention-deficit/hyperactivity disorder (ADHD) is a chronic, lifelong disorder with childhood-onset, which seriously impairs the affected adults in a variety of daily living functions like educational and occupational functioning, partnership and parenting.
ADHD is associated with a high percentage of comorbid psychiatric disorders in every lifespan. In adulthood between 65–89% of all patients with ADHD suffer from one or more additional psychiatric disorders, above all mood and anxiety disorders, substance use disorders and personality disorders, which complicates the clinical picture in terms of diagnostics, treatment and outcome issues. The present overview provides information of comorbid psychiatric disorders in adults with ADHD, underlying associations and clinical implications.
Similar content being viewed by others
References
Alm B, Sobanski E (2005) Angststörungen und Komorbidität mit Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) im Erwachsenenalter. In: Bassler M, Leydig S (eds) Psychotherapie der Angsterkrankungen. Thieme, Stuttgart New York, pp 143–154
Alpert JE, Maddocks A, Nierenberg AA et al. (1996) Attention deficit hyperactivity disorder in childhood among adults with major depression. Psychiatry Res 62:213–219
Babinski LM, Hartsough CS, Lambert NM (1999) Childhood conduct problems, hyperactivity-impulsivity and inattention as predictor of adult criminal activity. J Child Adolesc Psychiatry 40:347–355
Barkley RA, Fischer M, Smallish L, Fletcher K (2003) Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use abuse? A 13-year prospective study. Pediatrics 111:97–107
Biederman J, Faraone SV, Spencer T, Wilens T, Norman D, Lapey KA et al. (1993) Patterns of psychiatric comorbidity and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 150:1792–1797
Biederman J, Wilens T, Mick E et al. (1995) Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry 152:1652–1658
Biederman J et al. (1997) Is ADHD a risk factor for psychoactive substance use disorder. Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 36:21–29
Biederman J, Wilens TE, Mick E et al. (1998) Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence. Biol Psychiatry 44:269–273
Biederman J (2003) Pharmacotherapy of attention deficit hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHDJ Clin Psychiatry 64 (Suppl 11):3–8
Brown TE, McMullen WJ (2001) Attention deficit disorders and sleep/arousal disturbance. Ann N Y Acad Sci 931:271–286
Carroll KM, Rounsaville KJ (1993) History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr Psychiatry 34:75–83
Clure C, Brady KT, Saladin ME et al. (1999) Attention-deficit/hyperactivity disorder: symptom pattern and drug choice. Am J Drug Alcohol Abuse 25:441–448
Chervin RD, Dillon JE, Bassetti C, Ganoczy DA, Pituch KJ (1997) Symptoms of sleep disorder, inattention and hyperactivity. Sleep 20:1185–1192
Crabtree VM, Ivanenko A, O’Brien LM, Gozal D (2003) Periodic limb movement disorder of sleep in children. J Sleep Res 12:73–81
Faraone S, Biederman J (1997) Do attention deficit hyperactivity disorder and major depression share familial risk factors? J Nerv Ment Dis 185:533–541
Fones CS, Pollack MH, Susswein L, Otto M (2000) History of childhood attention-deficit/hyperactivity disorder (ADHD) features among adults with panic disorder. J Affect Disorder 58:99–106
Fossati A, Novella L, Donati D, Donini M, Maffei C (2002) History of childhood attention deficit/hyperactivity disorder symptoms and borderline personality disorder: a controlled study. Compr Psychiatry 43:369–377
Geller B, Zimmerman B, Williams M, Bolhoffer K, Craney JL et al. (2000) Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 10:157–164
Gillberg C, Gillberg IC, Rasmussen P, Kadesjö, B, Söderstöm H, Rastam M (2004) Co-existing disorders in ADHD—Implications for diagnosis and intervention. Eur Child Adolesc Psychiatry 13 (Suppl 1):80–92
Kessler RC, Adler L, Barkley R, Biedermann J et al. (2006) The prevalence and correlates of adult ADHD in the united States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163(4):716–723
Kooij JJS, Huub AM, Middelkoop AM, VanGils K, Buitelaar JK (2001) The effect of stimulants on nocturnal activity and sleep quality in adults with ADHD: an open-label case-control study. J Clin Psychiatry 62:952–955
Kooij JJS, Burger H, Boonstra AM, Linden PD van der, Kalma LE, Buitelaar JK (2004) Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled trial. Psychol Medicine 34:973–982
Manchini C, Ameringen M van, Oakman JM, Figueredo D (1999) Childhood attention-deficit/hyperactivity disorder in adults with anxiety disorders. Psychol Medicine 29:515–525
Manuzza S, Klein RG, Bessler A, Malloy P, La Padula M (1993) Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 50:565–567
Marks, Biederman J (2004) Impact of comorbidity in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 65 (Suppl 3):3–7
Murphy KR, Barkley RA, Bush T (2002) Young adults with attention-deficit hyperactivity disorder: subtype differences in comorbidity, education and clinical history. J Nerv Ment Dis 190:147–157
Nierenberg AA, Miyahara S, Spencer T, Wisniewski SR, Otto MW et al1. (2005) Clinical and diagnostic implications of lifetime comorbidity of attention-deficit/hyperactivity disorder in adults with bipolar disorder. Data from the first 1000 STEP-BD participants. Biol Psychiatry 57:1467–1473
Philipsen A, Feige B, Hesslinger B, Ebert D, Carl C et al. (2005) Sleep in adults with attention deficit hyperactivity disorder: a controlled polysomnographic study including spectral analysis of the sleep EEG. Sleep 28:738–745
Rasmussen P, Gillberg C (2000) Natural outcome of ADHD with developmental coordination disorder at age 22 years: A controlled, longitudinal, community-based study. J Am Acad Child Adolesc Psychiatry 39:1424–1431
Rösler M, Retz W, Retz-Junginger P, Hensch G, Schneider M, Supprian T (2004) Eur Arch Psychiatry Clin Neurosc 254:365–371
Sachs GS, Thase M (2000) Comorbidity of attention deficit hyperactivity disorder with early- and late-onset bipolar disorder. Am J Psychiatry 157:466–468
Satterfield JH, Schell A (1997) A prospective study of hyperactive boys with conduct disorder and normal boys: Adolescent and adult criminality. J Am Acad Child Adolesc Psychiatry 36:1726–1735
Shekim WO, Asarnow RF, Hess E, Zaucha K, Wheeler N (1990) A clinical and demographic profile of a sample of adults with attention-deficit hyperactivity disorder, residual state. Compr Psychiatry 31:416–425
Schubiner H, Tzelepis A, Millberger S et al. (2000) Prevalence of attention-deficit/hyperactivity disorder among substance use disorders. J Clin Psychiatry 61:244–251
Schweickert LA, Strober M, Moslowitz A (1997) Efficacy of methylphenidate in bulimia nervosa with comorbid attentiondeficit/hyperactivity disorder. Int J Eat Disord 21:299–301
Secnik K, Swenson A, Lange MJ (2005) Comorbidities and costs of adults with attention-deficit hyperactivity disorder. Pharmacoeconomics 23 (1):93–102
Sobanski E, Alm B (2004) Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) bei Erwachsenen: Ein Überblick. Nervenarzt 75:697–715
Sobanski E, Alm B, Krumm B (2006) Methylphenidatbehandlung bei erwachsenen Patienten mit Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS): Bedeutung von Störungssubtyp und psychiatrischer Komorbidität. Nervenarzt Mar 17 (E pub ahead of print)
Spencer T, Biederman J, Wilens T, Doyle R, Surman C, Prince J et al. (2005) A large double-blind, randomized trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 57:456–463
Thapar A, Harrington R, McGuffin P (2001) Examining the comorbidity of ADHD-related behaviours and conduct problems using a twin-study design. Brit J Psychiatry 179:224–229
Vermeiren R, de Clippele A, Deboutte D (2000) A descriptive survey of Flemish delinquent adolescents. J Adolesc 23:277–284
Wagner ML, Walters AS, Fisher BC (2004) Symptoms of attention-defict/hyperactivity disorder in adults with restless legs syndrome. Sleep 27 (8):1499–1504
Wender PH, Reimherr FW, Wood D, Ward M (1985) A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am J Psychiatry 142:547–552
Weiss G, Hechtman L, Milroy T et al. (1985) Psychiatric status of hyperactives as adults: A controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Adolesc Psychiatry 24:211–223
West S, McElroy, Strakowski S, Keck P, McConville B (1995) Attention-deficit hyperactivity disorder in adolesecent mania. J Affect Disord 51:145–151
Wilens TE, Biederman J, Prince J et al. (1996) Six-week, double-blind, placebo-controlled study of desipramine for adults with attention deficit hyperactivity disorder. Am J Psychiatry 153:1147–1153
Wilens TE et al. (1997) Attention deficit hyperactivity disorder (ADHD) is associated with early-onset substance use disorders. J Nerv Ment Dis 185:475–482
Wilens TE (2004) Impact of ADHD and its treatment on substance use disorders. J Clin Psychiatry 65:38–45
Wodarz N, Laufkötter R, Lange K, Johann N (2004) Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) bei erwachsenen Alkoholabhängigen. Nervenheilkunde 9:527–533
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sobanski, E. Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 256 (Suppl 1), i26–i31 (2006). https://doi.org/10.1007/s00406-006-1004-4
Issue Date:
DOI: https://doi.org/10.1007/s00406-006-1004-4